Abstract:Neuroinflammation and the underlying dysregulated immune responses of microglia actively contribute to the progression and, likely, the initiation of Alzheimer’s disease (AD). Fine-tuned therapeutic modulation of immune dysfunction to ameliorate disease cannot be achieved without the characterization of diverse microglial states that initiate unique, and sometimes contradictory, immune responses that evolve over time in chronic inflammatory environments. Because of the functional differences between human and murine microglia, untangling distinct, disease-relevant reactive states and their corresponding effects on pathology or neuronal health may not be possible without the use of human cells. In order to profile shifting microglial states in early AD and identify microglia-specific drivers of disease, we differentiated human induced pluripotent stem cells (iPSCs) carrying a familial AD PSEN2 mutation or its isogenic control into cerebral organoids and quantified the changes in cytokine concentrations over time with Luminex XMAP technology. We used partial least squares (PLS) modeling to build cytokine signatures predictive of disease and age to identify key differential patterns of cytokine expression that inform the overall organoid immune milieu and quantified the corresponding changes in protein pathology. AD organoids exhibited an overall reduction in cytokine secretion after an initial amplified immune response. We demonstrate that reduced synapse density observed in the AD organoids is prevented with microglial depletion. Crucially, these differential effects of dysregulated immune signaling occurred without the accumulation of pathological proteins. In this study, we used microglia-containing AD organoids to quantitatively characterize an evolving immune milieu, made up of a diverse of collection of activation patterns and immune responses, to identify how a dynamic, overall neuroinflammatory state negatively impacts neuronal health and the cell-specific contribution of microglia.

HIV-1 infection promotes neuroinflammation and neuron pathogenesis in novel microglia-containing cerebral organoids.

Modeling HIV-1 infection and NeuroHIV in hiPSCs-derived cerebral organoid cultures

Neuroinflammation generated by HIV-infected microglia promotes dysfunction and death of neurons in human brain organoids

A microglia-containing cerebral organoid model to study early life immune challenges

Microglia-containing cerebral organoids derived from induced pluripotent stem cells for the study of neurological diseases

HIV-1 infection of genetically engineered iPSC-derived central nervous system-engrafted microglia in a humanized mouse model

Generating Neuroimmune Assembloids Using Human Induced Pluripotent Stem Cell (iPSC)-Derived Cortical Organoids and Microglia

Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia.

Reconstitution of Human Immunodeficiency Virus-Induced Neurodegeneration Using Isolated Populations of Human Neurons, Astrocytes, and Microglia and Neuroprotection Mediated by Insulin-Like Growth Factors

Integration of iPSC-Derived Microglia into Brain Organoids for Neurological Research

Sporadic Creutzfeldt-Jakob disease infected human cerebral organoids retain the original human brain subtype features following transmission to humanized transgenic mice

Expression of the transcription factor PU.1 induces the generation of microglia-like cells in human cortical organoids

iPSC-derived three-dimensional brain organoid models and neurotropic viral infections

Human iPSC-derived neurons reveal NMDAR-independent dysfunction following HIV-associated insults

Dynamic neuroinflammatory profiles predict Alzheimer’s disease pathology in microglia-containing cerebral organoids

SARS-CoV-2 promotes microglial synapse elimination in human brain organoids

Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous system

Microglia-containing human brain organoids for the study of brain development and pathology.

Microglial- neuronal crosstalk in chronic viral infection through mTOR, SPP1/OPN and inflammasome pathway signaling

Development of a high-throughput, quantitative platform using human cerebral organoids to study virus-induced neuroinflammation in Alzheimer’s disease

Neuronal interactions in forebrain organoids lead to protective antiviral responses